Corgenix Medical Corporation (CONX) To Launch New Hepcidin-25 Product At The American Society of Hematology Annual Meeting
12/2/2013 7:24:01 AM
Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that it will launch the Research-Use-Only (RUO) Hepcidin-25 Chemiluminescent Direct ELISA test kit at the 55th Annual Meeting of the American Society of Hematology (ASH®) at the Ernest N. Morial Convention Center in New Orleans.
Help employers find you! Check out all the jobs and post your resume.